Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension
Authors:
- Cesare CuspidiCesare Cuspidi
- Marta RescaldaniMRMarta Rescaldani
- Carla SalaCSCarla Sala
- Francesca NegriFNFrancesca Negri
- Guido GrassiGGGuido Grassi
- Giuseppe ManciaGMGiuseppe Mancia
- 1 November 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 30 (11) , 2066-2073
Abstract
Left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular events in different clinical settings. We reviewed recent studies on the prevalence of hypertensive LVH, as assessed by ECG, in order to update our knowledge about this marker of cardiac organ damage in human hypertension. A MEDLINE search using the key words ' LVH ', 'hypertension', 'ECG', 'cardiac organ damage' and 'cardiac hypertrophy' was performed in order to identify relevant articles. Full articles published in English language in the last decade (1 January 2000 to 31 December 2010) reporting studies in adult or elderly individuals, were considered. A total of 26 studies, including 40 444 untreated and treated individuals (85% whites, 47% men, 32% obese, 28% diabetics and 22% patients with cardiovascular disease) were considered. LVH was defined by 15 criteria (seven studies used two or more criteria, range 2-7); LVH prevalence consistently varied among studies (0.6-40.0%) with an average of 18% in the pooled population. A sex-based analysis in five out of 26 studies (12 084 patients) showed an average prevalence of LVH of 24% in men and 16% in women (odds ratio 1.38, 95% CI 0.91-2.09, P = 0.11). Our analysis shows that LVH, as assessed by ECG, is present in a relevant fraction of the hypertensive population; these data highlight the role of ECG as a first-line examination for identifying subclinical organ damage and optimizing blood pressure control in hypertensive patients.Keywords
This publication has 40 references indexed in Scilit:
- Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure valuesJournal Of Hypertension, 2009
- Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic reviewBMJ, 2007
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Prognostic Significance of Electrocardiographic Voltages and Their Serial Changes in Elderly With Systolic HypertensionHypertension, 2004
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI studyJACC, 2001
- Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential HypertensionCirculation, 2001
- Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor RamiprilCirculation, 2001
- Prognostic implications of left ventricular hypertrophyAmerican Heart Journal, 2001